Showing posts with label neurons. Show all posts
Showing posts with label neurons. Show all posts

Saturday, 28 May 2016

Neuroscientists illuminate role of autism gene

Neuroscientists illuminate role of autism linked gene. Loss of Shank gene prevents neuronal synapses from properly maturing.


Scientia — A new study from MIT neuroscientists reveals that a gene mutation associated with autism plays a critical role in the formation and maturation of synapses — the connections that allow neurons to communicate with each other.


Autism, gene, Neuroscientists , neuronal , synapses , neurons, MIT , Shank3 , Cells


Many genetic variants have been linked to autism, but only a handful are potent enough to induce the disorder on their own. Among these variants, mutations in a gene called Shank3 are among the most common, occurring in about 0.5 percent of people with autism.





Scientists know that Shank3 helps cells respond to input from other neurons, but because there are two other Shank proteins, and all three can fill in for each other in certain ways, it has been difficult to determine exactly what the Shank proteins are doing.


“It’s clearly regulating something in the neuron that’s receiving a synaptic signal, but some people find one role and some people find another,” says Troy Littleton, a professor in the departments of Biology and of Brain and Cognitive Sciences at MIT, a member of MIT’s Picower Institute for Learning and Memory, and the senior author of the study. “There’s a lot of debate over what it really does at synapses.”


Key to the study is that fruit flies, which Littleton’s lab uses to study synapses, have only one version of the Shank gene. By knocking out that gene, the researchers eliminated all Shank protein from the flies.


“This is the first animal where we have completely removed all Shank family proteins,” says Kathryn Harris, a Picower Institute research scientist and lead author of the paper, which appears in the May 25 issue of the Journal of Neuroscience.


Synaptic organization


Scientists already knew that the Shank proteins are scaffold proteins, meaning that they help to organize the hundreds of other proteins found in the synapse of a postsynaptic cell — a cell that receives signals from a presynaptic cell. These proteins help to coordinate the cell’s response to the incoming signal.


“Shank is essentially a hub for signaling,” Harris says. “It brings in a lot of other partners and plays an organizational role at the postsynaptic membrane.”


In fruit flies lacking the Shank protein, the researchers found two dramatic effects. First, the postsynaptic cells had many fewer boutons, which are the sites where neurotransmitter release occurs. Second, many of the boutons that did form were not properly developed; that is, they were not surrounded by all of the postsynaptic proteins normally found there, which are required to respond to synaptic signals.


The researchers are now studying how this reduction in functional synapses affects the brain. Littleton suspects that the development of neural circuits could be impaired, which, if the same holds true in humans, may help explain some of the symptoms seen in autistic people.


“During critical windows of social and language learning, we reshape our connections to drive connectivity patterns that respond to rewards and language and social interactions,” he says. “If Shank is doing similar things in the mammalian brain, one could imagine potentially having those circuits form relatively normally early on, but if they fail to properly mature and form the proper number of connections, that could lead to a variety of behavioral defects.”


Pinpointing an exact link to autism symptoms would be difficult to do in fruit fly studies, however.





“Although the core molecular machines that allow neurons to communicate are highly conserved between fruit flies and humans, the anatomy of the various circuits that are formed during evolution are quite different,” Littleton says. “It’s hard to jump from a synaptic defect in the fly to an autism-like phenotype because the circuits are so different.”


An unexpected link


The researchers also showed, for the first time, that loss of Shank affects a well-known set of proteins that comprise the Wnt (also known as Wingless) signaling pathway. When a Wnt protein binds to a receptor on the cell, it initiates a series of interactions that influence which genes are turned on. This, in turn, contributes to many cell processes including embryonic development, tissue regeneration, and tumor formation.


When Shank is missing from fruit flies, Wnt signaling is disrupted because the receptor that normally binds to Wnt fails to be internalized by the cell. Normally, a small segment of the activated receptor moves to the cell nucleus and influences the transcription of genes that promote maturation of synapses. Without Shank, Wnt signaling is impaired and the synapses do not fully mature.


“The Shank protein and the Wnt protein family are thought to be involved in autism independently, but the fact that this study discovered that Wnt and Shank are interacting brings the story into better focus,” says Bryan Stewart, a professor of cell and systems biology at the University of Toronto at Mississauga, who was not involved in the research. “Now we can look and see if those interactions between Wnt and Shank are potentially responsible for their role in autism.”


The finding raises the possibility of treating autism with drugs that promote Wnt signaling, if the same connection is found in humans.


“Because the link to Wnt signaling is new and hasn’t been picked up in mammalian studies, we really hope that that can inspire people to look for a connection to Wnt signaling in mammalian models, and maybe that can offer another avenue for how loss of Shank could be counteracted,” Harris says.




– Credit and Resource –


The research was funded by the National Institutes of Health and the Simons Center for the Social Brain at MIT.


Anne Trafton | MIT News Office




Neuroscientists illuminate role of autism gene

Wednesday, 9 December 2015

Protein imaging reveals brain architecture

New technique could contribute to efforts to map the human brain.

Scientia — MIT chemical engineers and neuroscientists have developed a new way to classify neurons by labeling and imaging the proteins found in each cell. This type of imaging offers clues to each neuron’s function and should help in mapping the human brain, the researchers say.


Protein, brain, brain architecture, MIT, human brain, Brain, neuroscientists, neurons, cell, disease

Labeling different proteins in a single tissue sample offers a new way to classify neurons and other cells. On the top row, pyramidal neurons are shown in green, and different types of inhibitory interneurons are labeled red, blue, and orange. In the bottom row, at far left, interneurons only are labeled. The two middle images show blood vessels in cyan, and astrocytes in purple. At far right, every neuron in the sample is labeled green.
Courtesy of the researchers


“Each cell uses a unique combination of proteins. It’s basically a fingerprint,” says Kwanghun Chung, who is the Samuel A. Goldblith Assistant Professor in the Department of Chemical Engineering, a member of MIT’s Institute for Medical Engineering and Science (IMES) and Picower Institute for Learning and Memory, and the leader of the research team. “If you can look at expression patterns of many proteins, then you can guess each cell’s type and what it’s doing.”






Using this approach, the researchers were able to visualize 22 different proteins inside human brain slices, but the method could be scaled to analyze many more proteins and larger tissue samples. This could help scientists learn more about how diseases alter brain chemistry.


“Now, researchers will be able to investigate the differences between brains from disease models and normal animals, simultaneously looking at potentially dozens of different molecules. This is very important, as the individual variation between brains would make it difficult to make solid connections when looking at those same molecules, one at a time, between dozens of samples,” says graduate student Evan Murray, one of the lead authors of a paper describing the technique in the Dec. 3 issue of Cell.


The paper’s other lead authors are graduate students Jae Hun Cho, Daniel Goodwin, and Justin Swaney, and postdoc Taeyun Ku.


Using a novel method, researchers are able to image and label proteins found in each brain cell from a single tissue sample. Video: Melanie Gonick/MIT (protein imaging renderings courtesy of Kwanghun Chung and Evan Murray)

Label, rinse, repeat

The key advance of the new technology, known as SWITCH, is the ability to preserve tissue in such a way that it can be imaged repeatedly, with different proteins labeled each time.


To achieve that, the researchers devised a method for controlling the chemical reactions required for tissue preservation and labeling. This allows them to first preserve the tissue, then label a certain protein and image it. They can then wash away the tagging molecule and label a different protein, over and over again.


Controlling the chemical reactions requires a pair of buffers — solutions of weak acids and bases — that alter the tissue’s environment. One of the buffers, known as SWITCH-Off, halts most chemical reactions in the tissue, while the SWITCH-On buffer allows them to resume.




To prepare the tissue samples, the researchers first add the SWITCH-Off buffer, followed by chemicals necessary for tissue preservation, the most important of which is glutaraldehyde. Because the chemicals cannot react with any cells, they diffuse evenly throughout the sample. “It’s like these chemicals are in a stealth mode. They are not detected by tissue,” Chung says.


When the researchers add the SWITCH-On buffer, the glutaraldehyde forms a gel that preserves the tissue. The researchers also add detergent to destroy the lipids of the cell membranes, making the cell interiors more visible to a light microscope.


Once the tissue is preserved and ready for imaging, the researchers add the SWITCH-Off buffer again. With the tissue in an unreactive state, they add labels such as antibodies or dyes, which can be tailored to detect not only proteins but also DNA, neurotransmitters, or lipids. Once the labels have diffused through the tissue, adding the SWITCH-On buffer allows all cells to be exposed to the labels simultaneously.


Protein analysis

In the Cell study, the researchers labeled 22 different proteins in a small section of human brain tissue (roughly 3 millimeters by 3 millimeters by 0.1 millimeters). After 22 rounds of labeling, the tissue was still in good condition, so the researchers believe this technique could be used to image even more proteins.


They also examined the distribution of six proteins in human visual cortex tissue and were able to label and image the myelinated fibers that connect different regions of the brain. “If you can visualize these fibers then you can really understand brain connectivity and the fundamental laws that govern how these wires are formed and connected,” Chung says.


The size of the tissue that can be imaged is limited only by the amount of time required for labeling the proteins and imaging the sample.


It takes about a month for each labeling molecule to diffuse through a cubic-centimeter-sized tissue sample, but Chung and colleagues recently reported in the Proceedings of the National Academy of Sciences that they could speed this up dramatically by exposing the tissue to a randomly changing electric field. This cuts the diffusion time to about a day.


The imaging time depends on the type of microscope used. For this study, the researchers used a light sheet microscope, which can image samples about 100 times faster than a traditional light microscope. Using this microscope, it took about two hours to image an entire mouse brain, compared to about three days with a traditional microscope.


“There are other ways of doing proteomic imaging, but many of them are two-dimensional, or not scalable, or require special equipment,” Chung says. “But with this technique, anyone can do it and it’s scalable.”


Robert Brown, chair of neurology at the University of Massachusetts Medical School, says the new technique is part of a “new generation of imaging technology based on careful manipulation of biochemical structures.”


“It’s extraordinary because it allows one to look for multiple targets simultaneously in the same cell, with three-dimensional resolution, which has not been feasible with previous imaging methods,” he adds.


Chung’s lab will make detailed protocols and other resources available through its website. He now plans to start using SWITCH to study human neurological disorders and is also working on other technologies to help map the human brain.




– Credit and Resource –


Anne Trafton | MIT News Office




Protein imaging reveals brain architecture